GB

Gade Bakki Reddy

Active Director Director DIN 01672483
DIN 01672483 First appointment Dec 2004 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 6 historical roles
Total affiliations 8 Since Dec 2004
Shareholding value •••• Premium profile

About Gade Bakki Reddy

Data last updated:

Gade Bakki Reddy is a Director at Vvr Organics Private Limited (since 2008) and Director at Silicon Drugs & Intermediates Private Limited (since 2011). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹38.02 Cr; the largest is Vvr Organics Private Limited at ₹38.01 Cr (FY 2024). Earlier, Gade Bakki Reddy was a Director at Sai Teja Drugs And Intermidiates Private Limited (2007–2011) and Director at Silicon Life Sciences Private Limited (2008–2013) and 4 more.

DIN 01672483
Primary Designation Director
Industry Pharma
First Appointment 08 Dec 2004
Oldest Company Age 22 yrs
Largest company Vvr Organics Private Limited · ₹38.01 Cr (FY 2024)
Combined revenue ₹38.02 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vvr Organics Private Limited U24239TG2004PTC042540
Director14 Jul 20082004₹38.01 Cr (FY 2024)Active
Director25 Feb 20112011₹23,000 (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jul 20072000₹5.89 Cr (FY 2025)Active
Director19 Feb 20082008₹139 Cr (FY 2020)Amalgamated
Triwin Pharmaceuticals Limited U24230AP1995PLC021384
Director19 Jul 20101995₹17 Lakh (FY 2017)Active
Director08 Dec 20042004₹1.36 Cr (FY 2025)Active
Vazra Pharma Private Limited U24232TG2012PTC080426
Director20 Apr 20122012Strike Off
Director20 Apr 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Silicon Drugs & Intermediates Private Limited
Vazra Pharma Private Limited
Victory Life Sciences Hyd Private Limited
Vvr Organics Private Limited
Premium access

Shareholding and investment profile for Gade Bakki Reddy

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gade Bakki Reddy

Gade Bakki Reddy currently holds 2 directorships: Vvr Organics Private Limited (Director, since 14 Jul 2008, revenue ₹38.01 Cr (FY 2024)); Silicon Drugs & Intermediates Private Limited (Director, since 25 Feb 2011, revenue ₹23,000 (FY 2025)).

Gade Bakki Reddy was first appointed on 08 Dec 2004 as Director at Shree Vinayaka Life Sciences Private Limited. The most recent appointment on record is 20 Apr 2012 at Victory Life Sciences Hyd Private Limited.

The 2 current companies of Gade Bakki Reddy that report revenue have a combined latest revenue of ₹38.02 Cr: Vvr Organics Private Limited ₹38.01 Cr (FY 2024); Silicon Drugs & Intermediates Private Limited ₹23,000 (FY 2025).

Gade Bakki Reddy held 6 earlier board appointments: Sai Teja Drugs And Intermidiates Private Limited (Director, 25 Jul 2007 to 03 Jan 2011); Silicon Life Sciences Private Limited (Director, 19 Feb 2008 to 01 Nov 2013); Triwin Pharmaceuticals Limited (Director, 19 Jul 2010 to 10 Oct 2011); Shree Vinayaka Life Sciences Private Limited (Director, 08 Dec 2004 to 03 Jan 2011); Vazra Pharma Private Limited (Director, from 20 Apr 2012); and 1 more.

The current boards of Gade Bakki Reddy's companies include Addanki Siva Rama Prasad (Vvr Organics Private Limited), Varun Vihar Madupaduga (Vvr Organics Private Limited), Siva Nagi Reddy Vuyyuru (Silicon Drugs & Intermediates Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available